Microcap Ledger Shuttle Pharmaceuticals Holdings, Inc. $SHPH
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Gaithersburg, MD
- Fiscal year end
- December 31
- Shares outstanding
- 4,764,696 [10-Q 2026-09-24]
What the company doesAI summary of filing
Shuttle Pharmaceuticals Holdings, Inc. acquired substantially all assets of Molecule.ai in November 2025, a pharmaceutical software company that develops an artificial intelligence-driven platform for molecular discovery and early-stage drug development. The Molecule.ai platform combines AI techniques with scientific workflows to help researchers explore chemical space, evaluate molecular ideas, and make decisions during early drug development stages, with capabilities including molecular property prediction, cross-molecule evaluation, and prediction reasoning. The company generates revenue through licensing access to the Molecule.ai platform to pharmaceutical research customers. The company is a clinical-stage to pre-revenue entity that committed to winding down its clinical trials of Ropidoxuridine in November 2025 and is now focused on developing and commercializing the Molecule.ai platform. [10-K 2026-03-31]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | −$5.30M | −$2.98M | $90.2K | [10-Q 2026-09-24] |
| FY ended Dec 2025 | — | −$11.72M | −$9.48M | $334.0K | [10-K 2026-03-31] |
| FY ended Dec 2024 | — | −$9.14M | −$7.33M | $1.92M | [10-K 2026-03-31] |
- Quarterly cash burn
- −$1.49M
- Cash runway Estimate
- ~0.2 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-13 | 3,664,919 | [10-Q 2024-11-13] |
| 2025-02-24 | 4,076,567 | [10-K 2025-02-26] |
| 2025-05-08 | 10,984,291 | [10-Q 2025-05-08] |
| 2025-08-11 | 1,070,773 | [10-Q 2025-08-13] |
| 2025-11-11 | 1,603,285 | [10-Q 2025-11-13] |
| 2026-03-24 | 5,591,290 | [10-K 2026-03-31] |
| 2026-05-15 | 5,851,290 | [10-Q 2026-05-15] |
| 2026-09-21 | 4,764,696 | [10-Q 2026-09-24] |
- Shelf registration
- S-1 filed 2026-02-11; declared effective 2026-02-17 [S-1 2026-02-11]
Listing status
Current status: 4 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-08-28. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-08-28 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-08-28] |
| 2025-11-17 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-11-17] |
| 2025-03-13 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-03-13] |
| 2025-01-07 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-01-07] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-14 | Hrt Financial Lp | sell | 82,116 | $4.48 | [4 2026-07-15] |
| 2026-07-13 | Hrt Financial Lp | sell | 1,033 | $4.67 | [4 2026-07-15] |
| 2026-07-10 | Hrt Financial Lp | buy | 731 | $3.11 | [4 2026-07-13] |
| 2026-07-09 | Hrt Financial Lp | buy | 8,266 | $3.38 | [4 2026-07-13] |
| 2026-07-08 | Hrt Financial Lp | sell | 18,531 | $3.52 | [4 2026-07-09] |
| 2026-07-07 | Hrt Financial Lp | sell | 10,580 | $3.33 | [4 2026-07-09] |
| 2026-07-06 | Hrt Financial Lp | sell | 9,022 | $3.51 | [4 2026-07-07] |
| 2026-07-02 | Hrt Financial Lp | buy | 7,851 | $3.54 | [4 2026-07-07] |
| 2026-07-01 | Hrt Financial Lp | buy | 3,959 | $3.30 | [4 2026-07-02] |
| 2026-06-30 | Hrt Financial Lp | buy | 6,755 | $3.23 | [4 2026-07-01] |
| 2026-06-29 | Hrt Financial Lp | buy | 25,836 | $3.44 | [4 2026-07-01] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-24 | 10-Q | Quarterly report |
| 2026-09-16 | 8-K | Unregistered sale of equity |
| 2026-09-11 | 8-K | Shareholder vote results |
| 2026-09-02 | 8-K | Other events |
| 2026-09-01 | 8-K | Material agreement entered |
| 2026-08-28 | 8-K | Listing notice or transfer; Regulation FD disclosure |
| 2026-08-17 | NT 10-Q | Notice of late quarterly report |
| 2026-08-17 | 8-K | Acquisition or disposition completed |
| 2026-08-13 | DEF 14A | Proxy statement |
| 2026-08-03 | PRE 14A | Proxy statement |
| 2026-07-01 | 8-K | Regulation FD disclosure; Other events |
| 2026-06-11 | 8-K | Change to security holder rights; Charter, bylaws or fiscal year change |
Alerts for $SHPH
Email me when Shuttle Pharmaceuticals Holdings, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.